Download to XLS

Document and Entity Information

v2.4.0.8
Document and Entity Information (USD $)
12 Months Ended
Jan. 31, 2015
Jul. 31, 2014
Document And Entity Information    
Entity Registrant Name MamaMancini's Holdings, Inc.  
Entity Central Index Key 0001520358  
Document Type 10-K  
Document Period End Date Jan. 31, 2015  
Amendment Flag false  
Current Fiscal Year End Date --01-31  
Entity Well Known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Public Float   $ 23,590,184
Entity Common Stock, Shares Outstanding 26,047,376  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2015  

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Jan. 31, 2015
Jan. 31, 2014
Assets:    
Cash $ 854,995 $ 1,541,640
Accounts receivable, net 2,233,211 1,029,632
Inventories 301,170 159,829
Prepaid expenses 107,242 140,511
Due from manufacturer - related party 2,213,037 1,373,036
Total current assets 5,709,655 4,244,648
Property and equipment, net 1,124,745 978,027
Debt issuance costs, net 101,197 46,264
Total Assets 6,935,597 5,268,939
Liabilities:    
Accounts payable and accrued expenses 1,216,436 595,297
Line of credit 1,409,098 222,704
Term loan 120,000   
Total current liabilities 2,745,534 818,001
Term loan - net of current 440,000   
Convertible note - net of debt discount 1,587,447   
Total long-term liabilities 2,027,447   
Total Liabilities 4,772,981 818,001
Stockholders' Equity    
Preferred stock, $0.00001 par value; 20,000,000 shares authorized; no shares issued and outstanding      
Common stock, $0.00001 par value; 250,000,000 shares authorized; 26,407,376 and 24,187,375 shares issued and outstanding, respectively 260 242
Additional paid in capital 12,766,116 10,993,973
Common stock subscribed, $0.00001 par value; 66,667 and 833,333 shares, respectively 1 8
Accumulated deficit (10,603,761) (6,543,285)
Total Stockholders' Equity 2,162,616 4,450,938
Total Liabilities and Stockholders' Equity $ 6,935,597 $ 5,268,939

Consolidated Balance Sheets (Parenthetical)

v2.4.0.8
Consolidated Balance Sheets (Parenthetical) (USD $)
Jan. 31, 2015
Jan. 31, 2014
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 20,000,000 20,000,000
Preferred stock, shares issued      
Preferred stock, shares outstanding      
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 250,000,000 250,000,000
Common stock, shares issued 26,407,376 24,187,375
Common stock, shares outstanding 26,407,376 24,187,375
Common stock subscribed, par value $ 0.00001 $ 0.00001
Common stock subscribed, shares 66,667 833,333

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Income Statement [Abstract]      
Sales - net of slotting fees and discounts $ 775,252 $ 12,339,256 $ 8,741,621
Cost of sales 535,870 8,803,540 6,190,595
Gross profit 239,382 3,535,716 2,551,026
Operating expenses      
Research and development 8,477 100,864 19,408
General and administrative 472,023 7,185,042 5,470,586
Total operating expenses 480,500 7,285,906 5,489,994
Loss from operations (241,118) (3,750,190) (2,938,968)
Other expense      
Interest expense (2,526) (310,286) (8,640)
Total other expense (2,526) (310,286) (8,640)
Net loss $ (243,644) $ (4,060,476) $ (2,947,608)
Net loss per common share - basic and diluted $ (0.01) $ (0.16) $ (0.13)
Weighted average common shares outstanding - basic and diluted 24,187,375 25,487,778 22,012,920

Consolidated Statement of Changes in Stockholders' Equity

v2.4.0.8
Consolidated Statement of Changes in Stockholders' Equity (USD $)
Common Stock [Member]
Additional Paid In Capital [Member]
Common Stock Subscribed [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2012 $ 201 $ 5,804,680    $ (3,352,033) $ 2,452,848
Balance, shares at Dec. 31, 2012 20,054,000        
Common stock issued for cash 33 4,999,967       5,000,000
Common stock issued for cash, shares 3,333,375        
Stock options issued for services    162,933       162,933
Warrants issued for services    731,894       731,894
Common stock subscribed    799,995 5    800,000
Recapitalization 8 (295,008)       (295,000)
Recapitalization, shares 800,000        
Stock issuance costs    (1,604,000)       (1,604,000)
Net loss          (2,947,608) (2,947,608)
Balance at Dec. 31, 2013 242 10,600,461 5 (6,299,641) 4,301,067
Balance, shares at Dec. 31, 2013 24,187,375        
Stock options issued for services    2,015       2,015
Warrants issued for services    43,666       43,666
Common stock subscribed    449,997 3    450,000
Stock issuance costs    (102,166)       (102,166)
Net loss          (243,644) (243,644)
Balance at Jan. 31, 2014 242 10,993,973 8 (6,543,285) 4,450,938
Balance, shares at Jan. 31, 2014 24,187,375        
Stock options issued for services    94,775       94,775
Warrants issued for services    206,981       206,981
Common stock issued for services    136,587       136,587
Common stock issued for services, Shares 40,000        
Common stock issued 16 1,179,995 (8)   1,180,003
Common stock issued, shares 1,620,001        
Common stock subscribed    99,999 1    100,000
Stock issuance costs    (346,192)       (346,192)
Stock issued for debt financing 2 399,998       400,000
Stock issued for debt financing, shares 200,000        
Net loss          (4,060,476) (4,060,476)
Balance at Jan. 31, 2015 $ 260 $ 12,766,116 $ 1 $ (10,603,761) $ 2,162,616
Balance, shares at Jan. 31, 2015 26,047,376        

Consolidated Statement of Changes in Stockholders' Equity (Parenthetical)

v2.4.0.8
Consolidated Statement of Changes in Stockholders' Equity (Parenthetical)
Jan. 31, 2015
Jan. 31, 2014
Dec. 31, 2013
Statement of Stockholders' Equity [Abstract]      
Common stock subscribed, shares 66,667 833,333 533,333

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (243,644) $ (4,060,476) $ (2,947,608)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 4,141 170,113 33,891
Amortization of debt issuance costs 1,322 100,953   
Amortization of debt discount    46,197   
Share-based compensation 2,015 94,775 162,933
Stock issued for compensation    171,587   
Loss on disposition of fixed assets       15,343
(Increase) Decrease in:      
Accounts receivable 34,217 (1,203,579) (600,284)
Inventories (47,550) (141,341) (35,709)
Prepaid expenses (4,986) 33,269 (71,347)
Due from manufacturer - related party (232,009) (840,001) (788,871)
Increase (Decrease) in:      
Accounts payable and accrued expenses (227,747) 621,139 410,054
Net Cash Used In Operating Activities (714,241) (5,007,364) (3,821,598)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Cash paid for property and equipment (52,672) (316,831) (877,522)
Cash paid for acquisition of shell company       (295,000)
Loans to related party       (30,000)
Related party loans repaid       30,000
Net Cash Used In Investing Activities (52,672) (316,831) (1,172,522)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from issuance of common stock    1,180,003 5,000,000
Stock issuance costs (58,500) (174,211) (872,106)
Proceeds from common stock subscribed 450,000 100,000 800,000
Debt issuance costs (47,586) (214,636)   
Borrowings (repayment) of line of credit, net 222,704 1,186,394 (200,000)
Borrowings from term loan    600,000   
Repayment of term loan    (40,000)   
Borrowings from convertible note    2,000,000   
Net Cash Provided By Financing Activities 566,618 4,637,550 4,727,894
Net Decrease in Cash (200,295) (686,645) (266,226)
Cash - Beginning of Period 1,741,935 1,541,640 2,008,161
Cash - End of Period 1,541,640 854,995 1,741,935
Cash Paid During the Period for:      
Income taxes         
Interest 2,526 132,803 8,640
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:      
Stock issuance costs paid in the form of warrants 43,666 171,981 731,894
Machinery and equipment purchased on account       83,757
Debt discount on convertible note    $ 400,000   

Nature of Operations and Basis of Presentation

v2.4.0.8
Nature of Operations and Basis of Presentation
12 Months Ended
Jan. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Operations and Basis of Presentation

Note 1 - Nature of Operations and Basis of Presentation

 

Nature of Operations

 

MamaMancini’s Holdings, Inc. (the “Company”), (formerly known as Mascot Properties, Inc.) was organized on July 22, 2009 as a Nevada corporation.

 

Current Business of the Company

 

The Company is a manufacturer and distributor of beef meatballs with sauce, turkey meatballs with sauce, and other similar meats and sauces. The Company’s customers are located throughout the United States, with a large concentration in the Northeast and Southeast, and Canada.

 

Mergers

 

On January 24, 2013, the Company, Mascot Properties Acquisition Corp, a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), MamaMancini’s, Inc., a privately-held Delaware Corporation headquartered in New Jersey (“MamaMancini’s”) and an individual (the “Majority Shareholder”), entered into an Acquisition Agreement and Plan of Merger (the “Agreement”) pursuant to which the Merger Sub was merged with and into MamaMancini’s, with MamaMancini’s surviving as a wholly-owned subsidiary of the Company (the “Merger”). The Company acquired, through a reverse triangular merger, all of the outstanding capital stock of MamaMancini’s in exchange for issuing MamaMancini’s shareholders (the “MamaMancini’s Shareholders”), pro-rata, a total of 20,054,000 shares of the Company’s common stock. Immediately after the Merger was consummated, and further to the Agreement, the majority shareholders and certain affiliates of the Company cancelled a total of 103,408,000 shares of the Company’s common stock held by them (the “Cancellation”). In consideration of the Cancellation of such common stock, the Company paid the Majority Shareholder in aggregate of $295,000 and 800,000 shares of common stock and released the other affiliates from certain liabilities. In addition, the Company has agreed to spinout to the Majority Shareholder all assets related to the Company’s real estate management business within 30 days after the closing. As a result of the Merger and the Cancellation, the MamaMancini’s Shareholders became the majority shareholders of the Company.

 

The consolidated financial statements presented for all periods through and including January 31, 2015 are those of MamaMancini’s. As a result of this Merger, the equity sections of MamaMancini’s for all prior periods presented reflect the recapitalization described above and are consistent with the January 31, 2015 balance sheet presented for the Company.

 

Since the transaction is considered a reverse acquisition and recapitalization, the presentation of pro-forma financial information was not required.

 

Basis of Presentation

 

The consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.

Summary of Significant Accounting Policies

v2.4.0.8
Summary of Significant Accounting Policies
12 Months Ended
Jan. 31, 2015
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies

 

Change of Year End

 

Effective January 13, 2014, MamaMancini’s Holdings, Inc. (the “Company”) changed its fiscal year end date to January 31. The Company’s 2014 fiscal year commenced on February 1, 2014 and concludes on January 31, 2015. The Company changed its year end to be consistent with a significant number of its retail customers that have a fiscal year end on or near January 31. This allows the Company to more accurately account for accrued discounts and promotions to these retailers. The Company determined that recasting the prior year comparable period ended January 31, 2014 would not be material.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for doubtful accounts, inventory obsolescence, the fair value of share-based payments.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

Risks and Uncertainties

 

The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.

 

The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including the general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

 

Cash

 

The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at January 31, 2015 or 2014.

 

The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of January 31, 2015 and 2014, the Company had reserves of $2,000.

 

Inventories

 

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at January 31, 2015 and 2014:

 

    January 31, 2015     January 31, 2014  
Finished goods   $ 301,170     $ 159,829  
                 

 

Property and Equipment

 

Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives.

 

Asset lives for financial statement reporting of depreciation are:

 

Machinery and equipment   2-7 years
Furniture and fixtures   3-5 years
Leasehold improvements   3-10 years

 

Fair Value of Financial Instruments

 

For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short term financial instruments approximates fair value due to the relatively short period to maturity for these instruments.

 

Stock Issuance Costs

 

Stock issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity and netted against proceeds. In the event the costs are in excess of the proceeds, the costs are recorded to expense. In the case of an aborted offering, all costs are expensed. Offering costs recorded to equity for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014 were $346,192, $1,604,000 and $102,166, respectively. During the year ended January 31, 2015, the Company expensed $330,538 of deferred issuance costs related to the aborted offering of the Company’s common stock, which are included in general and administrative expenses in the consolidated statements of operations.

 

Research and Development

 

Research and development is expensed as incurred. Research and development expenses for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014 were $100,864, $19,408 and $8,477, respectively.

 

Shipping and Handling Costs

 

The Company classifies freight billed to customers as sales revenue and the related freight costs as cost of sales.

 

Revenue Recognition

 

The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products.

 

The Company meets these criteria upon shipment.

 

Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows:

 

    Year Ended
January 31, 2015
    Year Ended
December 31, 2013
    One Month Ended January 31, 2014  
Gross Sales   $ 12,725,100     $ 9,282,562     $ 796,177  
Less: Slotting, Discounts, Allowances     385,844       540,941       20,925  
Net Sales   $ 12,339,256     $ 8,741,621     $ 775,252  

 

Cost of Sales

 

Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs.

 

Advertising

 

Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014 were $3,104,088, $2,440,424 and $232,481, respectively.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Accounting for Stock-Based Compensation” (“ASC 718”) which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation cost for stock option plans in accordance with ASC 718. The Company accounts for share-based payments to non-employees in accordance with ASC 505-50 “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling Goods or Services”.

 

The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest.

 

Share-based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the Consolidated Statement of Operations. Share-based payments issued to placement agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid in capital.

 

For the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014 share-based compensation amounted to $438,343, $894,827 and $45,681, respectively. Of the $438,343, $894,827 and $45,681 recorded for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014, $171,981, $731,894 and $43,666 were direct costs of a stock offering and have been recorded as a reduction in additional paid in capital.

 

For the year ended January 31, 2015, when computing fair value of share-based payments, the Company has considered the following variables:

  

    January 31, 2015     December 31, 2013     January 31, 2014  
Risk-free interest rate     0.26% to 1.67%       0.61% to 1.01%       1.64 %
Expected life of grants     1 to 5 years       1 to 5 years       1 to 5 years  
Expected volatility of underlying stock     189% to 191%       144% to 193%       193 %
Dividends   $ 0     $ 0     $ 0  

 

The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

 

Earnings (Loss) Per Share

 

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss), adjusted for changes in income or loss that resulted from the assumed conversion of convertible shares, by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period.

 

The Company had the following potential common stock equivalents at January 31, 2015:

 

Common stock subscribed     66,667  
Common stock warrants, exercise price range of $1.00-$2.50     1,027,401  
Common stock options, exercise price of $1.00-$2.97     496,404  
Total common stock equivalents     1,683,472  

 

The Company had the following potential common stock equivalents at December 31, 2013:

 

Common stock subscribed     533,333  
Common stock warrants, exercise price of $1.00-$1.50     892,067  
Common stock options, exercise price of $1.00     428,845  
Total common stock equivalents     1,854,245  

 

The Company had the following potential common stock equivalents at January 31, 2014:

 

Common stock subscribed     833,333  
Common stock warrants, exercise price of $1.00-$1.50     922,067  
Common stock options, exercise price of $1.00     434,177  
Total common stock equivalents     2,189,577  

 

Since the Company reflected a net loss during the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014, the effect of considering any common stock equivalents, would have been anti-dilutive. A separate computation of diluted earnings (loss) per share is not presented.

 

Income Taxes

 

Income taxes are provided in accordance with ASC No. 740, “Accounting for Income Taxes”. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the period of deferred tax assets and liabilities.

 

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

The Company is no longer subject to tax examinations by tax authorities for years prior to 2012.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform to current period presentation.

 

Recent Accounting Pronouncements

 

The U.S. Financial Accounting Standards Board issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers, in May 2014. The amendments in this Update supersede the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments supersede the cost guidance in Subtopic 605-35, Revenue Recognition—Construction-Type and Production-Type Contracts, and create new Subtopic 340-40, Other Assets and Deferred Costs—Contracts with Customers. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2011-230—Revenue Recognition (Topic 605) and Proposed Accounting Standards Update 2011–250—Revenue Recognition (Topic 605): Codification Amendments, both of which have been deleted. Accounting Standards Update 2014-09. The amendments in this Update are effectively for the Company for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. The Company is currently evaluating the effects of ASU 2014-09 on the consolidated financial statements.

 

In June 2014, the Financial Accounting Standards Board issued Accounting Standards Update 2014-12, Compensation- Stock Compensation. The amendments in this update apply to reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target can be achieved after the requisite service period. This Accounting Standards Update is the final version of Proposed Accounting Standards Update EITF-13D—Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period, which has been deleted. The proposed amendments would apply to reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target could be achieved after the requisite service period. This Accounting Standards Update is the final version of Proposed Accounting Standards Update EITF-13D—Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period, which has been deleted. The amendments in this Update are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, and early adoption is permitted. The Company is currently evaluating the effects of ASU 2014-12 on the consolidated financial statements.

 

In August 2014, the Financial Accounting Standards Board issued Accounting Standards Update 2014–15, Presentation of Financial Statements – Going Concern. The Update provides U.S. GAAP guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2013–300—Presentation of Financial Statements (Topic 205): Disclosure of Uncertainties about an Entity’s Going Concern Presumption, which has been deleted. The Company is currently evaluating the effects of ASU 2014–15 on the consolidated financial statements.

 

In November 2014, the FASB issued Accounting Standards Update No. 2014-16 (ASU 2014-16), Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity. The amendments in this ASU do not change the current criteria in U.S. GAAP for determining when separation of certain embedded derivative features in a hybrid financial instrument is required. The amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of the host contract. The ASU applies to all entities that are issuers of, or investors in, hybrid financial instruments that are issued in the form of a share and is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the effects of ASU 2014–16 on the consolidated financial statements.

 

In March 2015, the Financial Accounting Standards Board issued Accounting issued Accounting Standards Update (ASU) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption of the amendments is permitted for financial statements that have not been previously issued. The amendments should be applied on a retrospective basis, wherein the balance sheet of each individual period presented should be adjusted to reflect the period-specific effects of applying the new guidance. Upon transition, an entity is required to comply with the applicable disclosures for a change in an accounting principle. These disclosures include the nature of and reason for the change in accounting principle, the transition method, a description of the prior-period information that has been retrospectively adjusted, and the effect of the change on the financial statement line items (i.e., debt issuance cost asset and the debt liability). The Company is currently evaluating the effects of ASU 2015-03 on the consolidated financial statements.

Property and Equipment

v2.4.0.8
Property and Equipment
12 Months Ended
Jan. 31, 2015
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 3 - Property and Equipment:

 

Property and equipment on January 31, 2015 and 2014 are as follows:

 

     January 31, 2015     January 31, 2014  
Machinery and Equipment   $ 1,060,066     $ 1,027,431  
Furniture and Fixtures     16,887       4,525  
Leasehold Improvements     274,567       2,733  
      1,351,520       1,034,689  
Less: Accumulated Depreciation     226,775       56,662  
    $ 1,124,745     $ 978,027  

 

At January 31, 2015 and 2014, fixed assets in the amount of $0 and $826,340, respectively, were not in service.

 

Depreciation expense charged to income for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014 amounted to $170,113, $33,891 and $4,141, respectively.

Investment in Meatball Obsession, LLC

v2.4.0.8
Investment in Meatball Obsession, LLC
12 Months Ended
Jan. 31, 2015
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]  
Investment in Meatball Obsession, LLC

Note 4 - Investment in Meatball Obsession, LLC

 

During 2011 the Company acquired a 34.62% interest in Meatball Obsession, LLC (“MO”) for a total investment of $27,032. This investment is accounted for using the equity method of accounting. Accordingly, investments are recorded at acquisition cost plus the Company’s equity in the undistributed earnings or losses of the entity.

 

At December 31, 2011 the investment was written down to $0 due to losses incurred by MO.

 

The Company’s ownership interest in MO has decreased due to dilution.

 

At January 31, 2015 and 2014, the Company’s ownership interest in MO was 12.6% and 15.8%, respectively.

Related Party Transactions

v2.4.0.8
Related Party Transactions
12 Months Ended
Jan. 31, 2015
Related Party Transactions [Abstract]  
Related Party Transactions

Note 5 - Related Party Transactions

 

Joseph Epstein Foods

 

On March 1, 2010, the Company entered into a five year agreement with Joseph Epstein Foods (the “Manufacturer”) who is a related party. The Manufacturer is owned by the CEO and President of the Company. The Company analyzed the relationship with the Manufacturer to determine if the Manufacturer is a variable interest entity as defined by FASB ASC 810 “Consolidation”. Based on this analysis, the Company has determined that the Manufacturer is a variable interest but the Company is not the primary beneficiary of the variable interest entity and therefore consolidation is not required. Under the terms of the agreement, the Company grants to the Manufacturer a revocable license to use the Company’s recipes, formulas, methods and ingredients for the preparation and production of Company’s products, for manufacturing the Company’s product and all future improvements, modifications, substitutions and replacements developed by the Company. The Manufacturer in turn grants the Company the exclusive right to purchase the product. Under the terms of the agreement the Manufacturer agrees to manufacture, package, and store the Company’s products and the Company has the right to purchase products from one or more other manufacturers, distributors or suppliers. The agreement contains a perpetual automatic renewal clause for a period of one year after the expiration of the initial term. During the renewal period either party may cancel the contract with written notice nine months prior to the termination date.

 

Under the terms of the agreement if the Company specifies any change in packaging or shipping materials which results in the manufacturer incurring increased expense for packaging and shipping materials or in the Manufacturer being unable to utilize obsolete packaging or shipping materials in ordinary packaging or shipping, the Company agrees to pay as additional product cost the additional cost for packaging and shipping materials and to purchase at cost such obsolete packaging and shipping materials. If the Company requests any repackaging of the product, other than due to defects in the original packaging, the Company will reimburse the Manufacturer for any labor costs incurred in repackaging. Per the agreement, all product delivery shipping costs are the expense of the Company.

 

In addition, the Company made several unsecured loans to the Manufacturer during the year ended 2013, the one month period ended January 31 2014, and the year ended January 31, 2015. The loan to the Manufacturer is unsecured, does not bear interest and is due on demand.

 

During the year ended January 31, 2015 and the one month ended January 31, 2014, the Company made improvements to the Manufacturer’s facility. The improvements have been capitalized and are being depreciated over the estimated useful life of the supply agreement.

 

During the year ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014, the Company purchased substantially all of its inventory from the Manufacturer. 

 

During the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014, the Manufacturer incurred expenses on behalf of the Company for shared administrative expenses and salary expenses.

 

At January 31, 2015 and 2014 the amount due from the Manufacturer is $2,213,037 and $1,373,036, respectively.

 

Meatball Obsession, LLC

 

A current director of the Company is the chairman of the board and shareholder of Meatball Obsession LLC.

 

For the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014, the Company generated approximately $113,600, $85,500 and $0 in revenues from MO, respectively.

 

As of January 31, 2015 and 2014, the Company had a receivable of $6,768 and $1,457 due from MO, respectively.

Line of Credit

v2.4.0.8
Line of Credit
12 Months Ended
Jan. 31, 2015
Debt Disclosure [Abstract]  
Line of Credit

Note 6 - Line of Credit

 

Effective January 3, 2014, the Company entered into a Sale and Security Agreement (the “Sale and Security Agreement”) with Faunus Group International, Inc. (“FGI”) to provide for a $1.5 million secured demand credit facility backed by its receivables and inventory (the “FGI Facility”). The Sale and Security Agreement has an initial three year term (the “Original Term”) and shall be extended automatically for an additional one year for each succeeding term unless written notice of termination is given by either party at least sixty days prior to the end of the Original Term or any extension thereof. The Company and certain of its affiliates also entered into guarantees to guarantee the performance of the obligations under the Sale and Security Agreement (the “Guaranty Agreements”). The Company also granted FGI a security interest in and lien upon all of the Company’s right, title and interest in and to all of its assets (as defined in the Sale and Security Agreement).

 

Pursuant to the FGI Facility, FGI can elect to purchase eligible accounts receivables (“Purchased Accounts”) up to 70% of the value of such receivables (retaining a 30% reserve). At FGI’s election, FGI may advance the Company up to 70% of the value of any Purchased Accounts, subject to the FGI Facility. Reserves retained by FGI on any Purchased Accounts are expected to be refunded to the Company net of interest and fees on advances once the receivables are collected from customers. The interest rate on advances or borrowings under the FGI Facility will be the greater of (i) 6.75% per annum and (ii) 2.50% above the prime rate. Any advances or borrowings under the FGI Facility are due on demand.

 

The Company also agreed to pay to FGI monthly collateral management fees of 0.42% of the average monthly balance of Purchased Accounts. The minimum monthly net funds employed during each contract year hereof shall be $500,000. Additionally, the Company paid FGI a one-time facility fee equal to 1% of the FGI Facility upon entry into the Sale and Security Agreement.

 

During the year ended January 31, 2015, the Company terminated its agreement with FGI and paid off all obligations due at the payoff date. Upon termination, additional fees and accrued interest of approximately $48,600 were paid and included in the interest expense.

Loan and Security Agreement

v2.4.0.8
Loan and Security Agreement
12 Months Ended
Jan. 31, 2015
Loan And Security Agreement  
Loan and Security Agreement

Note 7 - Loan and Security Agreement

 

On September 3, 2014, the Company entered into a Loan and Security Agreement (“Loan and Security Agreement”) with Entrepreneur Growth Capital, LLC (“EGC”). The total facility is for an aggregate principal amount of up to $3,100,000. The facility consists of the following:

 

Accounts Revolving Line of Credit:   $ 2,150,000  
Inventory Revolving Line of Credit:   $ 350,000  
Term Loan:   $ 600,000  

 

EGC may from time to time make loans in an aggregate amount not to exceed the Accounts Revolving Line of Credit up to 85% of the net amount of Eligible Accounts (as defined in the Loan and Security Agreement). EGC may from time to time make loans in an aggregate amount not to exceed the Inventory Revolving Line of Credit against Eligible Inventory (as defined in the Loan and Security Agreement) in an amount up to 50% of finished goods and in an amount up to 20% of raw material.

 

The revolving interest rates is equal to the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus (a) 2.5% on loans and advances made against eligible accounts and (b) 4.0% on loans made against eligible inventory. The term loan bears interest at a rate of the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0%. The initial term of the facility is for a period of two years and will automatically renew for an additional one year period. The Company is required to pay a one-time facility fee equal to 2.25% of the total $3,100,000 facility. In the event of default, the Company shall pay 10% above the stated rates of interest per the Agreement. The drawdowns are secured by all of the assets of the Company.

 

On September 3, 2014, the Company also entered into a 5 year $600,000 Secured Promissory Note (“EGC Note”) with EGC. The EGC Note is payable in 60 monthly installments of $10,000. The EGC Note bears interest at the prime rate plus 4.0% and is payable monthly, in arrears. In the event of default, the Company shall pay 10% above the stated rates of interest per the Loan and Security Agreement. The EGC Note is secured by all of the assets of the Company. The outstanding balance on the note was $560,000 as of January 31, 2015.

 

Additionally, in connection with the Loan and Security Agreement, Carl Wolf, the Company’s Chief Executive Officer entered into a Guarantee Agreement with EGC, personally guaranteeing all the amounts borrowed on behalf of the Company under the Loan and Security Agreement.

Convertible Note

v2.4.0.8
Convertible Note
12 Months Ended
Jan. 31, 2015
Debt Disclosure [Abstract]  
Convertible Note

Note 8 – Convertible Note

 

On December 19, 2014, the Company entered into a securities purchase agreement (the “Manatuck Purchase Agreement”) with Manatuck Hill Partners, LLC (“Manatuck”) whereby the Company issued a convertible redeemable debenture (the “Manatuck Debenture”) in favor of Manatuck. The Manatuck Debenture is for $2,000,000 bearing interest at a rate of 14% and matures in February 2016. Upon issuance of the Manatuck Debenture, the Company granted Manatuck 200,000 shares of the Company’s restricted common stock. Subsequent to January 31, 2015, the maturity date was extended to May 2016.

 

Optional conversion to convertible preferred stock is available upon completion of a qualified offering (as defined in the Manatuck Purchase Agreement) while the Manatuck Debenture is outstanding. Upon conversion of the Manatuck Debenture, the Company shall issue Manatuck shares of common stock as defined in the Manatuck Purchase Agreement.

 

Upon issuance of the debenture, a debt discount of $458,750 was recorded for the fees incurred by the buyer as well as the value of the common shares granted to Manatuck. The debt discount will be amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt, using the straight-line method which approximates the interest method. The amortization of debt discount is included as a component of interest expense in the consolidated statements of operations. There was unamortized debt discount of $412,553 as of January 31, 2015.

Concentrations

v2.4.0.8
Concentrations
12 Months Ended
Jan. 31, 2015
Risks and Uncertainties [Abstract]  
Concentrations

Note 9 - Concentrations

 

Revenues

 

During the year ended January 31, 2015, the Company earned revenues from three customers representing approximately 18%, 13% and 11% of gross sales. As of January 31, 2015, the customers represented approximately 23%, 12%, and 15% of total gross outstanding receivables, respectively.

 

During the year ended December 31, 2013, the Company earned revenues from four customers representing approximately 18%, 17%, 14%, and 14% of gross sales. As of December 31, 2013, the customers represented approximately 16%, 23%, 14% and 4% of total gross outstanding receivables, respectively.

 

During the one month ended January 31, 2014, three customers represented 18%, 15% and 10% of gross sales. As of January 31, 2014, the customers represented approximately 8%, 24%, and 8% of total gross outstanding receivables, respectively.

 

Cost of Sales

 

For the year ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014, one vendor (a related party) represented 95% of the Company’s purchases.

Stockholders' Equity

v2.4.0.8
Stockholders' Equity
12 Months Ended
Jan. 31, 2015
Equity [Abstract]  
Stockholders' Equity

Note 10 - Stockholders’ Equity

 

(A) Common Stock Transactions

 

As a result of the reverse merger (see Note 1) the Company had a deemed issuance of 800,000 shares of common stock.

 

From July 1, 2013 through December 31, 2013, the Company issued 3,333,375 shares of common stock to investors in exchange for $5,000,000 in proceeds in connection with the private placement of the Company’s stock.

 

During December 2013, the Company sold 533,333 shares of common stock to investors in exchange for $800,000 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in March 2014.

 

In connection with the private placement the Company incurred fees of $1,604,000 consisting of $872,106 in cash and 30,000 warrants with a fair value of $731,894.

 

During January 2014, the Company sold 300,000 shares of common stock to investors in exchange for $450,000 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in March 2014.

 

In connection with the private placement the Company incurred fees of $102,166 consisting of $58,500 in cash and 30,000 warrants with a fair value of $43,666.

 

During March 2014, the Company sold 236,667 shares of common stock to investors in exchange for $355,000 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in June 2014.

 

In connection with the private placement the Company incurred fees of $80,536 consisting of $46,150 in cash and 23,667 warrants with a fair value of $34,386.

 

During April 2014, the Company sold 416,668 shares of common stock to investors in exchange for $625,001 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in June 2014.

 

In connection with the private placement the Company incurred fees of $141,791 consisting of $81,250 in cash and 41,667 warrants with a fair value of $60,541.

 

During May 2014, the Company sold 133,333 shares of common stock to investors in exchange for $200,002 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in June 2014.

 

In connection with the private placement the Company incurred fees of $82,796 consisting of $26,000 in cash and 17,333 warrants with a fair value of $56,796.

 

During October 2014, the Company granted 14,000 warrants to a consultant upon termination of the original agreement. The shares were valued at grant date and the Company recorded $35,000 as share-based compensation on the Consolidated Statement of Operations.

 

In October 2014, the Board agreed to amend a previously issued stock option grant awarded to the Board members. Instead of the 50,000 options (10,000 per member), the Company issued each member 8,000 shares of restricted stock. The options were originally granted on April 23, 2014 with a grant date fair value of $136,587. The Company reclassified this amount from stock based compensation to common stock issued for services on the Consolidated Statements of Equity. The shares were not issued as of January 31, 2015.

 

On December 19, 2014, the Company issued a convertible redeemable debenture (the “Manatuck Debenture” as discussed in Note 8). Upon issuance of the Manatuck Debenture, the Company granted Manatuck 200,000 shares of the Company’s restricted common stock. 

 

Common Stock Subscribed

 

During June 2014, the Company sold 66,668 shares of common stock to investors in exchange for $100,000 in proceeds in connection with the private placement of the Company’s stock. The shares were not issued as of January 31, 2015.

 

In connection with the private placement the Company incurred fees of $33,258 consisting of $13,000 in cash and 8,667 warrants with a fair value of $20,258.

 

(B) Options

 

The following is a summary of the Company’s option activity:

 

      Options     Weighted
Average
Exercise Price
 
               
Outstanding – January 1, 2013       223,404     $ 1.00  
Exercisable – January 1, 2013       -     $ -  
Granted       318,000     $ 1.00  
Exercised       -     $ -  
Forfeited/Cancelled       -     $ -  
Outstanding – December 31, 2013       541,404     $ 1.00  
Exercisable – December 31, 2013       428,845     $ 1.00  
Granted       -     $ -  
Exercised       -     $ -  
Forfeited/Cancelled       -     $ -  
Outstanding – January 31, 2014       541,404     $ 1.00  
Exercisable – January 31, 2014       434,177     $ 1.00  
Granted       59,000     $ 2.95  
Exercised       -     $ -  
Forfeited/Cancelled       (104,000 )   $ -  
Outstanding – January 31, 2015       496,404     $ 1.04  
Exercisable – January 31, 2015       496,404     $ 1.02  

 

Options Outstanding   Options Exercisable  
Exercise Price     Number Outstanding     Weighted
Average
Remaining
Contractual
Life
(in years)
  Weighted
Average
Exercise Price
    Number
Exercisable
    Weighted
Average
Exercise Price
 
                                         
$ 1.00       487,404     2.71 years   $ 1.00       481,404     $ 0.65  
$ 2.97       9,000     4.25 years   $ 2.97       4,500     $ 2.00  

 

At January 31, 2015 and 2014, the total intrinsic value of options outstanding and exercisable was $219,332 and $1,082,808, respectively.

 

As of January 31, 2015, the Company has $3,055 in stock-based compensation related to stock options that is yet to be vested. The weighted average remaining life of the options is 2.74 years.

 

(C) Warrants

 

The following is a summary of the Company’s warrant activity:

 

      Warrants     Weighted
Average
Exercise Price
 
               
Outstanding – January 1, 2013       505,400     $ 1.00  
Exercisable – January 1, 2013       -     $ -  
Granted       386,667     $ 1.50  
Exercised       -     $ -  
Forfeited/Cancelled       -     $ -  
Outstanding – December 31, 2013       892,067     $ 1.22  
Exercisable – December 31, 2013       892,067     $ 1.22  
Granted       30,000     $ 1.50  
Exercised       -     $ -  
Forfeited/Cancelled       -     $ -  
Outstanding – January 31, 2014       922,067     $ 1.22  
Exercisable – January 31, 2014       922,067     $ 1.22  
Granted       203,334     $ 2.05  
Exercised       -     $ -  
Forfeited/Cancelled       (98,000 )   $ -  
Outstanding – January 31, 2015       1,027,401     $ 1.27  
Exercisable – January 31, 2015       1,027,401     $ 1.27  

 

Warrants Outstanding   Warrants Exercisable
Range of
Exercise Price
  Number
Outstanding
    Weighted
Average
Remaining
Contractual Life
(in years)
  Weighted
Average
Exercise Price
    Number Exercisable   Weighted
Average
Exercise Price
 
                                 
$1.00-$2.50     1,027,401     3.12 years   $ 1.27     1,027,401   $ 1.27  

 

During the year ended January 31, 2015, the Company terminated a consulting agreement which resulted in the forfeiture of 98,000 warrants which were awarded upon execution of the original agreement.

 

At January 31, 2015 and 2014, the total intrinsic value of warrants outstanding and exercisable was $227,430 and $1,635,801, respectively.

Commitments and Contingencies

v2.4.0.8
Commitments and Contingencies
12 Months Ended
Jan. 31, 2015
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 11 - Commitments and Contingencies

 

Litigations, Claims and Assessments

 

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company is currently not aware of any such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results.

 

Licensing and Royalty Agreements

 

On March 1, 2010, the Company was assigned a Development and License agreement (the “Agreement”). Under the terms of the Agreement the Licensor shall develop for the Company a line of beef meatballs with sauce, turkey meatballs with sauce and other similar meats and sauces for commercial manufacture, distribution and sale (each a “Licensor Product” and collectively the “Licensor Products”). Licensor shall work with Licensee to develop Licensor Products that are acceptable to Licensee. Upon acceptance of a Licensor Product by Licensee, Licensor’s trade secret recipes, formulas methods and ingredients for the preparation and production of such Licensor Products (the “Recipes”) shall be subject to this Development and License Agreement.

 

The term of the Agreement (the “Term”) shall consist of the Exclusive Term and the Non-Exclusive Term. The 12-month period beginning on each January 1 and ending on each December 31 is referred to herein as an “Agreement Year.”

 

The Exclusive Term began on January 1, 2009 (the “Effective Date”) and ends on the 50th anniversary of the Effective Date, unless terminated or extended as provided herein. Licensor, at its option, may terminate the Exclusive Term by notice in writing to Licensee, delivered between the 60th and the 90th day following the end of any Agreement Year if, on or before the 60th day following the end of such Agreement Year, Licensee has not paid Licensor Royalties with respect to such Agreement Year at least equal to the minimum royalty (the “Minimum Royalty”) for such Agreement Year. Subject to the foregoing sentence, and provided Licensee has not breached this Agreement and failed to cure such breach in accordance herewith, Licensee may extend the Exclusive Term for an additional twenty five (25) years, by notice in writing to Licensor, delivered on or before the 50th anniversary of the Effective Date.

 

The Non-Exclusive Term begins upon expiration of the Exclusive Term and continues indefinitely thereafter, until terminated by Licensor due to a material breach hereof by Licensee that remains uncured after notice and opportunity to cure in accordance herewith, or until terminated by Licensee.

 

Either party may terminate this Agreement in the event that the other party materially breaches its obligations and fails to cure such material breach within sixty (60) days following written notice from the non-breaching party specifying the nature of the breach. The following termination rights are in addition to the termination rights provided elsewhere in the agreement

 

  Termination by Licensee - Licensee shall have the right to terminate this Agreement at any time on sixty (60) days written notice to Licensor. In such event, all moneys paid to Licensor shall be deemed non-refundable.

 

Under the terms of the Agreement the Company is required to pay quarterly royalty fees as follows:

 

During the Exclusive Term and the Non-Exclusive Term the Company will pay a royalty equal to the royalty rate (the “Royalty Rate”), multiplied by Company’s “Net Sales”. As used herein, “Net Sales” means gross invoiced sales of Products, directly or indirectly to unrelated third parties, less (a) discounts (including cash discounts), and retroactive price reductions or allowances actually allowed or granted from the billed amount (collectively “Discounts”); (b) credits, rebates, and allowances actually granted upon claims, rejections or returns, including recalls (voluntary or otherwise) (collectively, “Credits”); (c) freight, postage, shipping and insurance charges; (d) taxes, duties or other governmental charges levied on or measured by the billing amount, when included in billing, as adjusted for rebates and refunds; and (e) provisions for uncollectible accounts determined in accordance with reasonable accounting methods, consistently applied.

 

The Royalty Rate shall be: 6% of net sales up to $500,000 of net sales for each Agreement year; 4% of Net Sales from $500,000 up to $2,500,000 of Net Sales for each Agreement year; 2% of Net Sales from $2,500,000 up to $20,000,000 of Net Sales for each Agreement year; and 1% of Net Sales in excess of $20,000,000 of Net Sales for each Agreement year.

 

In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows:

 

Agreement Year   Minimum Royalty to
be Paid with Respect
to Such Agreement
Year
 
1st and 2nd   $ -  
3rd and 4th   $ 50,000  
5th, 6th and 7th   $ 75,000  
8th and 9th   $ 100,000  
10th and thereafter   $ 125,000  

 

The Company incurred $284,861, $203,031 and $35,551 of royalty expenses for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014. Royalty expenses are included in general and administrative expenses on the Consolidated Statement of Operations.

 

Agreements with Placement Agents and Finders

 

(A) December 1, 2011

 

The Company entered into a Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective December 1, 2011 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $6 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).

 

The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.

 

Along with the above fees, the Company shall pay up to $40,000 for expenses incurred by Spartan in connection with this Financing, together with cost of background checks on the officers and directors of the Company.

 

During the year ended 2012 the Company paid to Spartan fees of $505,400 and issued Spartan 505,400 five year warrants with an exercise price of $1.00.

 

(B) May 2, 2013

 

The Company entered into a second Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective May 2, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).

 

The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and up to 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.

 

The Company shall pay to Spartan a non-refundable monthly fee of $10,000 over a twelve to twenty four month period upon Spartan’s satisfaction of certain thresholds (raising of aggregate gross proceeds of $4.0mil-$5.0mil) outlined in the Spartan Advisory Agreement. On October 29, 2013 the Company entered into an amendment to the Agreement and the $10,000 monthly fee was cancelled.

 

During the year ended December 31, 2013 the Company paid to Spartan fees of $650,000 and issued Spartan 333,333 five year warrants with an exercise price of $1.50.

 

(C) October 22, 2013

 

The Company entered into a third Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective October 22, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act, for a minimum of twenty-four months from the date of the agreement, as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $2.5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).

 

The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.

 

The Company shall pay to Spartan a non-refundable monthly fee of $10,000 for the term of the agreement. Such monthly fee shall survive any termination of the Agreement.

 

During the year ended December 31, 2013 the Company paid to Spartan financing fees of $104,000 and issued Spartan 53,333 five year warrants with an exercise price of $1.50 and a grant date fair value of $731,894.

 

During the month ended January 31, 2014 the Company paid to Spartan financing fees of $58,500 and issued Spartan 30,000 five year warrants with an exercise price of $1.50 and a grant date fair value of $43,166.

 

During the year ended January 31, 2015, the Company paid to Spartan financing fees of $166,400 and issued Spartan 91,333 five year warrants with an exercise price of $1.50 and a grant date fair value of $171,981.

 

Operating Lease

 

In January 2015, the Company began a lease agreement for office space in East Rutherford, NJ. The lease is for a 39 month term expiring on March 31, 2019 with annual payments of $18,848.

 

Total future minimum payments required under operating lease as of January 31, 2015 are as follows.

 

January 31,        
2016     $ 18,848  
2017       18,848  
2018       18,848  
2019       18,848  
2020       3,141  
      $ 78,533  

Income Tax Provision (Benefit)

v2.4.0.8
Income Tax Provision (Benefit)
12 Months Ended
Jan. 31, 2015
Income Tax Disclosure [Abstract]  
Income Tax Provision (Benefit)

Note 12 – Income Tax Provision (Benefit)

 

The income tax provision (benefit) consists of the following:

 

    January 31, 2015     January 31, 2014  
Federal                
Current   $ -     $ -  
Deferred     (1,376,168 )     (81,819 )
State and Local                
Current     -       -  
Deferred     (369,301 )     (21,825 )
Change in valuation allowance     1,745,469       103,644  
Income tax provision (benefit)   $ -     $ -  

 

The Company has U.S. federal net operating loss carryovers (NOLs) of approximately $8.8M and $4.8M at January 31, 2015 and 2014, respectively, available to offset taxable income through 2034. If not used, these NOLs may be subject to limitation under Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under the regulations. The Company plans on undertaking a detailed analysis of any historical and/or current Section 382 ownership changes that may limit the utilization of the net operating loss carryovers. The Company also has New Jersey State Net Operating Loss carry overs of $8.8M and $4.8M at January 31, 2015 and 2014, respectively, available to offset future taxable income through 2034.

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon future generation for taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all the information available, Management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended January 31, 2015 and the one month ended January 31, 2014, the change in the valuation allowance was $1,745,469 and $103,644.

 

The Company evaluated the provisions of ASC 740 related to the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740 prescribes a comprehensive model for how a company should recognize, present, and disclose uncertain positions that the Company has taken or expects to take in its tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the net benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits.” A liability is recognized (or amount of net operating loss carry forward or amount of tax refundable is reduced) for unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740.

 

If applicable, interest costs related to the unrecognized tax benefits are required to be calculated and would be classified as “Other expenses – Interest” in the statement of operations. Penalties would be recognized as a component of “General and administrative.”

 

No interest or penalties on unpaid tax were recorded during the year ended January 31, 2015 and the one month ended January 31, 2014, respectively. As of January 31, 2015 and 2014, no liability for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax benefits in the next year.

 

The Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following:

 

Deferred Tax Assets   Year Ended January 31, 2015     One Month Ended January 31, 2014  
             
Net operating loss carryovers   $ 3,855,903     $ 2,044,894  
                 
Total deferred tax assets     3,855,903       2,044,894  
Valuation allowance     (3,754,914 )     (2,009,445 )
Deferred tax asset, net of valuation allowance     100,989       35,449  
                 
Deferred Tax Liabilities                
Other deferred tax liabilities     (100,989 )     (35,449 )
Total deferred tax liabilities   $ (100,989 )   $ (35,449 )
Net deferred tax asset (liability)   $ -     $ -  

 

The expected tax expense (benefit) based on the statutory rate is reconciled with actual tax expense benefit as follows:

 

    Year Ended January 31, 2015     One Month Ended January 31, 2014  
             
US Federal statutory rate     (34.00 )%     (34.00 )%
State income tax, net of federal benefit     (5.9 )     (5.9 )
Deferred tax true-up     -       -  
Change in valuation allowance     43.0       42.5  
Other permanent differences     (3.0 )     (2.6 )
Income tax provision (benefit)     - %     - %

Summary of Significant Accounting Policies (Policies)

v2.4.0.8
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Jan. 31, 2015
Accounting Policies [Abstract]  
Change of Year End

Change of Year End

 

Effective January 13, 2014, MamaMancini’s Holdings, Inc. (the “Company”) changed its fiscal year end date to January 31. The Company’s 2014 fiscal year commenced on February 1, 2014 and concludes on January 31, 2015. The Company changed its year end to be consistent with a significant number of its retail customers that have a fiscal year end on or near January 31. This allows the Company to more accurately account for accrued discounts and promotions to these retailers. The Company determined that recasting the prior year comparable period ended January 31, 2014 would not be material.

Use of Estimates

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for doubtful accounts, inventory obsolescence, the fair value of share-based payments.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

Risks and Uncertainties

Risks and Uncertainties

 

The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.

 

The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including the general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

Cash

Cash

 

The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at January 31, 2015 or 2014.

 

The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of January 31, 2015 and 2014, the Company had reserves of $2,000.

Inventories

Inventories

 

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at January 31, 2015 and 2014:

 

    January 31, 2015     January 31, 2014  
Finished goods   $ 301,170     $ 159,829  

Property and Equipment

Property and Equipment

 

Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives.

 

Asset lives for financial statement reporting of depreciation are:

 

Machinery and equipment   2-7 years
Furniture and fixtures   3-5 years
Leasehold improvements   3-10 years

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short term financial instruments approximates fair value due to the relatively short period to maturity for these instruments.

Stock Issuance Costs

Stock Issuance Costs

 

Stock issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity and netted against proceeds. In the event the costs are in excess of the proceeds, the costs are recorded to expense. In the case of an aborted offering, all costs are expensed. Offering costs recorded to equity for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014 were $346,192, $1,604,000 and $102,166, respectively. During the year ended January 31, 2015, the Company expensed $330,538 of deferred issuance costs related to the aborted offering of the Company’s common stock, which are included in general and administrative expenses in the consolidated statements of operations.

Research and Development

Research and Development

 

Research and development is expensed as incurred. Research and development expenses for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014 were $100,864, $19,408 and $8,477, respectively.

Shipping and Handling Costs

Shipping and Handling Costs

 

The Company classifies freight billed to customers as sales revenue and the related freight costs as cost of sales.

Revenue Recognition

Revenue Recognition

 

The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products.

 

The Company meets these criteria upon shipment.

Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows:

 

    Year Ended
January 31, 2015
    Year Ended
December 31, 2013
    One Month Ended January 31, 2014  
Gross Sales   $ 12,725,100     $ 9,282,562     $ 796,177  
Less: Slotting, Discounts, Allowances     385,844       540,941       20,925  
Net Sales   $ 12,339,256     $ 8,741,621     $ 775,252  

Cost of Sales

Cost of Sales

 

Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs.

Advertising

Advertising

 

Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014 were $3,104,088, $2,440,424 and $232,481, respectively.

Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Accounting for Stock-Based Compensation” (“ASC 718”) which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation cost for stock option plans in accordance with ASC 718. The Company accounts for share-based payments to non-employees in accordance with ASC 505-50 “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling Goods or Services”.

 

The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest.

 

Share-based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the Consolidated Statement of Operations. Share-based payments issued to placement agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid in capital.

 

For the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014 share-based compensation amounted to $438,343, $894,827 and $45,681, respectively. Of the $438,343, $894,827 and $45,681 recorded for the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014, $171,981, $731,894 and $43,666 were direct costs of a stock offering and have been recorded as a reduction in additional paid in capital.

 

For the year ended January 31, 2015, when computing fair value of share-based payments, the Company has considered the following variables:

  

    January 31, 2015     December 31, 2013     January 31, 2014  
Risk-free interest rate     0.26% to 1.67%       0.61% to 1.01%       1.64 %
Expected life of grants     1 to 5 years       1 to 5 years       1 to 5 years  
Expected volatility of underlying stock     189% to 191%       144% to 193%       193 %
Dividends   $ 0     $ 0     $ 0  

 

The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

Earnings (Loss) Per Share

Earnings (Loss) Per Share

 

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss), adjusted for changes in income or loss that resulted from the assumed conversion of convertible shares, by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period.

 

The Company had the following potential common stock equivalents at January 31, 2015:

 

Common stock subscribed     66,667  
Common stock warrants, exercise price range of $1.00-$2.50     1,027,401  
Common stock options, exercise price of $1.00-$2.97     496,404  
Total common stock equivalents     1,683,472  

 

The Company had the following potential common stock equivalents at December 31, 2013:

 

Common stock subscribed     533,333  
Common stock warrants, exercise price of $1.00-$1.50     892,067  
Common stock options, exercise price of $1.00     428,845  
Total common stock equivalents     1,854,245  

 

The Company had the following potential common stock equivalents at January 31, 2014:

 

Common stock subscribed     833,333  
Common stock warrants, exercise price of $1.00-$1.50     922,067  
Common stock options, exercise price of $1.00     434,177  
Total common stock equivalents     2,189,577  

 

Since the Company reflected a net loss during the years ended January 31, 2015 and December 31, 2013 and the one month ended January 31, 2014, the effect of considering any common stock equivalents, would have been anti-dilutive. A separate computation of diluted earnings (loss) per share is not presented.

Income Taxes

Income Taxes

 

Income taxes are provided in accordance with ASC No. 740, “Accounting for Income Taxes”. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the period of deferred tax assets and liabilities.

 

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

 

The Company is no longer subject to tax examinations by tax authorities for years prior to 2012.

Reclassification

Reclassification

 

Certain prior period amounts have been reclassified to conform to current period presentation.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

The U.S. Financial Accounting Standards Board issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers, in May 2014. The amendments in this Update supersede the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments supersede the cost guidance in Subtopic 605-35, Revenue Recognition—Construction-Type and Production-Type Contracts, and create new Subtopic 340-40, Other Assets and Deferred Costs—Contracts with Customers. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2011-230—Revenue Recognition (Topic 605) and Proposed Accounting Standards Update 2011–250—Revenue Recognition (Topic 605): Codification Amendments, both of which have been deleted. Accounting Standards Update 2014-09. The amendments in this Update are effectively for the Company for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. The Company is currently evaluating the effects of ASU 2014-09 on the consolidated financial statements.

 

In June 2014, the Financial Accounting Standards Board issued Accounting Standards Update 2014-12, Compensation- Stock Compensation. The amendments in this update apply to reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target can be achieved after the requisite service period. This Accounting Standards Update is the final version of Proposed Accounting Standards Update EITF-13D—Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period, which has been deleted. The proposed amendments would apply to reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target could be achieved after the requisite service period. This Accounting Standards Update is the final version of Proposed Accounting Standards Update EITF-13D—Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period, which has been deleted. The amendments in this Update are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, and early adoption is permitted. The Company is currently evaluating the effects of ASU 2014-12 on the consolidated financial statements.

 

In August 2014, the Financial Accounting Standards Board issued Accounting Standards Update 2014–15, Presentation of Financial Statements – Going Concern. The Update provides U.S. GAAP guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2013–300—Presentation of Financial Statements (Topic 205): Disclosure of Uncertainties about an Entity’s Going Concern Presumption, which has been deleted. The Company is currently evaluating the effects of ASU 2014–15 on the consolidated financial statements.

 

In November 2014, the FASB issued Accounting Standards Update No. 2014-16 (ASU 2014-16), Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity. The amendments in this ASU do not change the current criteria in U.S. GAAP for determining when separation of certain embedded derivative features in a hybrid financial instrument is required. The amendments clarify that an entity should consider all relevant terms and features, including the embedded derivative feature being evaluated for bifurcation, in evaluating the nature of the host contract. The ASU applies to all entities that are issuers of, or investors in, hybrid financial instruments that are issued in the form of a share and is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the effects of ASU 2014–16 on the consolidated financial statements.

 

In March 2015, the Financial Accounting Standards Board issued Accounting issued Accounting Standards Update (ASU) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption of the amendments is permitted for financial statements that have not been previously issued. The amendments should be applied on a retrospective basis, wherein the balance sheet of each individual period presented should be adjusted to reflect the period-specific effects of applying the new guidance. Upon transition, an entity is required to comply with the applicable disclosures for a change in an accounting principle. These disclosures include the nature of and reason for the change in accounting principle, the transition method, a description of the prior-period information that has been retrospectively adjusted, and the effect of the change on the financial statement line items (i.e., debt issuance cost asset and the debt liability). The Company is currently evaluating the effects of ASU 2015-03 on the consolidated financial statements.

Summary of Significant Accounting Policies (Tables)

v2.4.0.8
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jan. 31, 2015
Accounting Policies [Abstract]  
Schedule of Inventories

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at January 31, 2015 and 2014:

 

    January 31, 2015     January 31, 2014  
Finished goods   $ 301,170     $ 159,829  

Schedule of Property and Equipment Estimated Useful Lives

Asset lives for financial statement reporting of depreciation are:

 

Machinery and equipment   2-7 years
Furniture and fixtures   3-5 years
Leasehold improvements   3-10 years

Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction

Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows:

 

    Year Ended
January 31, 2015
    Year Ended
December 31, 2013
    One Month Ended January 31, 2014  
Gross Sales   $ 12,725,100     $ 9,282,562     $ 796,177  
Less: Slotting, Discounts, Allowances     385,844       540,941       20,925  
Net Sales   $ 12,339,256     $ 8,741,621     $ 775,252  

Schedule of Fair Value of Share Based Payments

For the year ended January 31, 2015, when computing fair value of share-based payments, the Company has considered the following variables:

  

    January 31, 2015     December 31, 2013     January 31, 2014  
Risk-free interest rate     0.26% to 1.67%       0.61% to 1.01%       1.64 %
Expected life of grants     1 to 5 years       1 to 5 years       1 to 5 years  
Expected volatility of underlying stock     189% to 191%       144% to 193%       193 %
Dividends   $ 0     $ 0     $ 0  

Schedule of Common Stock Equivalents

The Company had the following potential common stock equivalents at January 31, 2015:

 

Common stock subscribed     66,667  
Common stock warrants, exercise price range of $1.00-$2.50     1,027,401  
Common stock options, exercise price of $1.00-$2.97     496,404  
Total common stock equivalents     1,683,472  

 

The Company had the following potential common stock equivalents at December 31, 2013:

 

Common stock subscribed     533,333  
Common stock warrants, exercise price of $1.00-$1.50     892,067  
Common stock options, exercise price of $1.00     428,845  
Total common stock equivalents     1,854,245  

 

The Company had the following potential common stock equivalents at January 31, 2014:

 

Common stock subscribed     833,333  
Common stock warrants, exercise price of $1.00-$1.50     922,067  
Common stock options, exercise price of $1.00     434,177  
Total common stock equivalents     2,189,577  

Property and Equipment (Tables)

v2.4.0.8
Property and Equipment (Tables)
12 Months Ended
Jan. 31, 2015
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment on January 31, 2015 and 2014 are as follows:

 

     January 31, 2015     January 31, 2014  
Machinery and Equipment   $ 1,060,066     $ 1,027,431  
Furniture and Fixtures     16,887       4,525  
Leasehold Improvements     274,567       2,733  
      1,351,520       1,034,689  
Less: Accumulated Depreciation     226,775       56,662  
    $ 1,124,745     $ 978,027  

Loan and Security Agreement (Tables)

v2.4.0.8
Loan and Security Agreement (Tables)
12 Months Ended
Jan. 31, 2015
Loan And Security Agreement  
Schedule of Line of Credit

The facility consists of the following:

 

Accounts Revolving Line of Credit:   $ 2,150,000  
Inventory Revolving Line of Credit:   $ 350,000  
Term Loan:   $ 600,000  

Stockholders' Equity (Tables)

v2.4.0.8
Stockholders' Equity (Tables)
12 Months Ended
Jan. 31, 2015
Equity [Abstract]  
Summary of Option Activity

The following is a summary of the Company’s option activity:

 

      Options     Weighted
Average
Exercise Price
 
               
Outstanding – January 1, 2013       223,404     $ 1.00  
Exercisable – January 1, 2013       -     $ -  
Granted       318,000     $ 1.00  
Exercised       -     $ -  
Forfeited/Cancelled       -     $ -  
Outstanding – December 31, 2013       541,404     $ 1.00  
Exercisable – December 31, 2013       428,845     $ 1.00  
Granted       -     $ -  
Exercised       -     $ -  
Forfeited/Cancelled       -     $ -  
Outstanding – January 31, 2014       541,404     $ 1.00  
Exercisable – January 31, 2014       434,177     $ 1.00  
Granted       59,000     $ 2.95  
Exercised       -     $ -  
Forfeited/Cancelled       (104,000 )   $ -  
Outstanding – January 31, 2015       496,404     $ 1.04  
Exercisable – January 31, 2015       496,404     $ 1.02  

Summary of Option Outstanding and Exercisable

Options Outstanding   Options Exercisable  
Exercise Price     Number Outstanding     Weighted
Average
Remaining
Contractual
Life
(in years)
  Weighted
Average
Exercise Price
    Number
Exercisable
    Weighted
Average
Exercise Price
 
                                         
$ 1.00       487,404     2.71 years   $ 1.00       481,404     $ 0.65  
$ 2.97       9,000     4.25 years   $ 2.97       4,500     $ 2.00  

Schedule of Warrants Activity

The following is a summary of the Company’s warrant activity:

 

      Warrants     Weighted
Average
Exercise Price
 
               
Outstanding – January 1, 2013       505,400     $ 1.00  
Exercisable – January 1, 2013       -     $ -  
Granted       386,667     $ 1.50  
Exercised       -     $ -  
Forfeited/Cancelled       -     $ -  
Outstanding – December 31, 2013       892,067     $ 1.22  
Exercisable – December 31, 2013       892,067     $ 1.22  
Granted       30,000     $ 1.50  
Exercised       -     $ -  
Forfeited/Cancelled       -     $ -  
Outstanding – January 31, 2014       922,067     $ 1.22  
Exercisable – January 31, 2014       922,067     $ 1.22  
Granted       203,334     $ 2.05  
Exercised       -     $ -  
Forfeited/Cancelled       (98,000 )   $ -  
Outstanding – January 31, 2015       1,027,401     $ 1.27  
Exercisable – January 31, 2015       1,027,401     $ 1.27  

Schedule of Warrants Outstanding and Exercisable

Warrants Outstanding   Warrants Exercisable
Range of
Exercise Price
  Number
Outstanding
    Weighted
Average
Remaining
Contractual Life
(in years)
  Weighted
Average
Exercise Price
    Number Exercisable   Weighted
Average
Exercise Price
 
                                 
$1.00-$2.50     1,027,401     3.12 years   $ 1.27     1,027,401   $ 1.27  

Commitments and Contingencies (Tables)

v2.4.0.8
Commitments and Contingencies (Tables)
12 Months Ended
Jan. 31, 2015
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Royalty Minimum Payment by Preceding Agreement Year

In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows:

 

Agreement Year   Minimum Royalty to
be Paid with Respect
to Such Agreement
Year
 
1st and 2nd   $ -  
3rd and 4th   $ 50,000  
5th, 6th and 7th   $ 75,000  
8th and 9th   $ 100,000  
10th and thereafter   $ 125,000  

Schedule of Future Minimum Payments Under Operating Leases

Total future minimum payments required under operating lease as of January 31, 2015 are as follows.

 

January 31,        
2016     $ 18,848  
2017       18,848  
2018       18,848  
2019       18,848  
2020       3,141  
      $ 78,533  

Income Tax Provision (Benefit) (Tables)

v2.4.0.8
Income Tax Provision (Benefit) (Tables)
12 Months Ended
Jan. 31, 2015
Income Tax Disclosure [Abstract]  
Schedule of Provision for Income Tax

The income tax provision (benefit) consists of the following:

 

    January 31, 2015     January 31, 2014  
Federal                
Current   $ -     $ -  
Deferred     (1,376,168 )     (81,819 )
State and Local                
Current     -       -  
Deferred     (369,301 )     (21,825 )
Change in valuation allowance     1,745,469       103,644  
Income tax provision (benefit)   $ -     $ -  

Schedule of Deferred Tax Assets

The Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following:

 

Deferred Tax Assets   Year Ended January 31, 2015     One Month Ended January 31, 2014  
             
Net operating loss carryovers   $ 3,855,903     $ 2,044,894  
                 
Total deferred tax assets     3,855,903       2,044,894  
Valuation allowance     (3,754,914 )     (2,009,445 )
Deferred tax asset, net of valuation allowance     100,989       35,449  
                 
Deferred Tax Liabilities                
Other deferred tax liabilities     (100,989 )     (35,449 )
Total deferred tax liabilities   $ (100,989 )   $ (35,449 )
Net deferred tax asset (liability)   $ -     $ -  

Schedule of Effective Income Tax Rate Reconciliation

The expected tax expense (benefit) based on the statutory rate is reconciled with actual tax expense benefit as follows:

 

    Year Ended January 31, 2015     One Month Ended January 31, 2014  
             
US Federal statutory rate     (34.00 )%     (34.00 )%
State income tax, net of federal benefit     (5.9 )     (5.9 )
Deferred tax true-up     -       -  
Change in valuation allowance     43.0       42.5  
Other permanent differences     (3.0 )     (2.6 )
Income tax provision (benefit)     - %     - %

Nature of Operations and Basis of Presentation (Details Narrative)

v2.4.0.8
Nature of Operations and Basis of Presentation (Details Narrative) (USD $)
0 Months Ended
Jan. 24, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of shares issued in exchange for acquisition 20,054,000
Number of shares cancelled 103,408,000
Aggregate amount paid in cancellation to majority shareholders $ 295,000
Stock issued for consideration of common stock cancellation for majority shareholders 800,000

Summary of Significant Accounting Policies (Details Narrative)

v2.4.0.8
Summary of Significant Accounting Policies (Details Narrative) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Accounting Policies [Abstract]      
Cash equivalents $ 0 $ 0  
Accounts receivable reserves 2,000 2,000  
Stock offering cost recorded 102,166 346,192 1,604,000
Deferred issuance costs   330,538  
Research and development expense 8,477 100,864 19,408
Advertising expenses 232,481 3,104,088 2,440,424
Share based compensation 45,681 438,343 894,827
Reduction in additional paid in capital $ 43,666 $ 171,981 $ 731,894

Summary of Significant Accounting Policies - Schedule of Inventories (Details)

v2.4.0.8
Summary of Significant Accounting Policies - Schedule of Inventories (Details) (USD $)
Jan. 31, 2015
Jan. 31, 2014
Accounting Policies [Abstract]    
Finished goods $ 301,170 $ 159,829

Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details)

v2.4.0.8
Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details)
12 Months Ended
Jan. 31, 2015
Minimum [Member] | Machinery And Equipment [Member]
 
Property and equipment estimated useful lives 2 years
Minimum [Member] | Furniture And Fixtures [Member]
 
Property and equipment estimated useful lives 3 years
Minimum [Member] | Leasehold Improvements [Member]
 
Property and equipment estimated useful lives 3 years
Maximum [Member] | Machinery And Equipment [Member]
 
Property and equipment estimated useful lives 7 years
Maximum [Member] | Furniture And Fixtures [Member]
 
Property and equipment estimated useful lives 5 years
Maximum [Member] | Leasehold Improvements [Member]
 
Property and equipment estimated useful lives 10 years

Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction (Details)

v2.4.0.8
Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction (Details) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Accounting Policies [Abstract]      
Gross Sales $ 796,177 $ 12,725,100 $ 9,282,562
Less: Slotting, Discounts, Allowances 20,925 385,844 540,941
Net Sales $ 775,252 $ 12,339,256 $ 8,741,621

Summary of Significant Accounting Policies - Schedule of Fair Value of Share Based Payments (Details)

v2.4.0.8
Summary of Significant Accounting Policies - Schedule of Fair Value of Share Based Payments (Details)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Risk-free interest rate, minimum   0.26% 0.61%
Risk-free interest rate, maximum   1.67% 1.01%
Risk-free interest rate 1.64%    
Expected volatility of underlying stock, minimum   189.00% 144.00%
Expected volatility of underlying stock, maximum   191.00% 193.00%
Expected volatility of underlying stock 193.00%    
Dividend 0.00% 0.00% 0.00%
Minimum [Member]
     
Expected life of grants 1 year 1 year 1 year
Maximum [Member]
     
Expected life of grants 5 years 5 years 5 years

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details)

v2.4.0.8
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details)
Jan. 31, 2015
Jan. 31, 2014
Dec. 31, 2013
Accounting Policies [Abstract]      
Common stock subscribed, shares 66,667 833,333 533,333
Common stock warrants, exercise price range of $1.00-$2.50 1,027,401    
Common stock warrants, exercise price range of $1.00-$1.50   922,067 892,067
Common stock options, exercise price of $1.00-$2.97 496,404 434,177 428,845
Total common stock equivalents 1,683,472 2,189,577 1,854,245

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) (Parenthetical)

v2.4.0.8
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) (Parenthetical) (USD $)
Jan. 31, 2015
Jan. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Common stock options, exercise price $ 1.04 $ 1.00 $ 1.00 $ 1.00
Minimum [Member]
       
Common stock warrants, exercise price range $ 1.00 $ 1.00 $ 1.00  
Common stock options, exercise price $ 1.00      
Maximum [Member]
       
Common stock warrants, exercise price range $ 2.50 $ 1.50 $ 1.50  
Common stock options, exercise price $ 2.97      

Property and Equipment (Details Narrative)

v2.4.0.8
Property and Equipment (Details Narrative) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Property, Plant and Equipment [Abstract]      
Fixed assets amount $ 826,340 $ 0  
Depreciation expense $ 4,141 $ 170,113 $ 33,891

Property and Equipment - Schedule of Property and Equipment (Details)

v2.4.0.8
Property and Equipment - Schedule of Property and Equipment (Details) (USD $)
Jan. 31, 2015
Jan. 31, 2014
Property, Plant and Equipment [Abstract]    
Machinery and Equipment $ 1,060,066 $ 1,027,431
Furniture and Fixtures 16,887 4,525
Leasehold Improvements 274,567 2,733
Property Plant And Equipment, Gross 1,351,520 1,034,689
Less: Accumulated Depreciation 226,775 56,662
Property, plant and equipment, net $ 1,124,745 $ 978,027

Investment in Meatball Obsession, LLC (Details Narrative)

v2.4.0.8
Investment in Meatball Obsession, LLC (Details Narrative) (Meatball Obsession, LLC [Member], USD $)
0 Months Ended
Dec. 31, 2011
Jan. 31, 2015
Jan. 31, 2014
Meatball Obsession, LLC [Member]
     
Percentage of equity interest acquired in business combination 34.62%    
Total investment in Meatball Obsession, LLC $ 27,032    
Reduction in investment due to losses in affiliates $ 0    
Ownership interest percentage   12.60% 15.80%

Related Party Transactions (Details Narrative)

v2.4.0.8
Related Party Transactions (Details Narrative) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Due from manufacturer - related party $ 1,373,036 $ 2,213,037  
Meatball Obsession, LLC [Member]
     
Revenue from related parties 0 113,600 85,500
Due from related party $ 1,457 $ 6,768  

Line of Credit (Details Narrative)

v2.4.0.8
Line of Credit (Details Narrative) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Jan. 31, 2015
Faunus Group International, Inc. [Member]
Guaranty Agreements [Member]
Jan. 03, 2014
Secured Demand Credit Facility Backed By Receivables and Inventory [Member]
Secured demand credit facility backed by its receivables and inventory         $ 1,500,000
Purchased eligible accounts receivables, percentage       70.00%  
Percentage of reserve on purchased eligible accounts receivables       30.00%  
Interest rate on advances or borrowings under the FGI Facility      

The greater of (i) 6.75% per annum and (ii) 2.50% above the prime rate.

 
Collateral management fees, percentage of average monthly balance of Purchased Accounts       0.42%  
Minimum monthly net funds employed during each contract year       500,000  
One-time facility fee, percentage of credit facility upon entry into Sale and Security Agreement       1.00%  
Additional fees and accrued interest paid $ 2,526 $ 132,803 $ 8,640 $ 48,600  

Loan and Security Agreement (Details Narrative)

v2.4.0.8
Loan and Security Agreement (Details Narrative) (USD $)
0 Months Ended
Sep. 03, 2014
Jan. 31, 2015
Line of credit aggregate value $ 600,000  
Loan And Security Agreement One [Member] | Entrepreneur Growth Capital LLC [Member]
   
Line of credit aggregate value 3,100,000  
Percentage of accounts revolving line of credit maximum 85.00%  
Percentage of finished goods amount 50.00%  
Percentage of raw material amount 20.00%  
Line of credit interest rate description

Generally reported by Citibank, N.A. plus (a) 2.5% on loans and advances made against eligible accounts and (b) 4.0% on loans made against eligible inventory. The term loan bears interest at a rate of the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0%. 

 
Line of credit annual facility percentage 2.25%  
Line of credit default stated rates of interest 10.00%  
Loan And Security Agreement Two [Member] | Entrepreneur Growth Capital LLC [Member]
   
Line of credit aggregate value 600,000  
Line of credit interest rate description

The Note bears interest at highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0% and is payable monthly.

 
Line of credit default stated rates of interest 10.00%  
Term of loan 5 years  
Repayment of secured debt, monthly installment basis 10,000  
Note payable, during period 60 months  
Note payable   $ 560,000

Loan and Security Agreement - Schedule of Line of Credit (Details)

v2.4.0.8
Loan and Security Agreement - Schedule of Line of Credit (Details) (USD $)
Sep. 03, 2014
Loan And Security Agreement  
Accounts Revolving Line of Credit: $ 2,150,000
Inventory Revolving Line of Credit: 350,000
Term Loan: $ 600,000

Convertible Note (Details Narrative)

v2.4.0.8
Convertible Note (Details Narrative) (USD $)
1 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Dec. 19, 2014
Manatuck Hill Partners, LLC [Member]
Dec. 19, 2014
Manatuck Purchase Agreement [Member]
Manatuck Hill Partners, LLC [Member]
Jan. 31, 2015
Manatuck Purchase Agreement [Member]
Manatuck Hill Partners, LLC [Member]
Convertible debenture         $ 2,000,000  
Debt bearing interest rate         14.00%  
Debt maturity month year         February 2016  
Number of restricted common stock shares granted, shares       200,000 200,000  
Debt maturity extended month year           May 2016
Debt discount 1,322 100,953        458,750
Unamortized debt discount   $ 412,553        

Concentrations (Details Narrative)

v2.4.0.8
Concentrations (Details Narrative)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Customer A [Member]
     
Concentrations of risk percentage 18.00% 18.00% 18.00%
Percentage of outstanding receivables 8.00% 23.00% 16.00%
Customer B [Member]
     
Concentrations of risk percentage 15.00% 13.00% 17.00%
Percentage of outstanding receivables 24.00% 12.00% 23.00%
Customer C [Member]
     
Concentrations of risk percentage 10.00% 11.00% 14.00%
Percentage of outstanding receivables 8.00% 15.00% 14.00%
Customer D [Member]
     
Concentrations of risk percentage     14.00%
Percentage of outstanding receivables     4.00%
Vendor One [Member]
     
Percentage of cost of sales during period 95.00% 95.00% 95.00%

Stockholders' Equity (Details Narrative)

v2.4.0.8
Stockholders' Equity (Details Narrative) (USD $)
1 Months Ended 12 Months Ended 1 Months Ended 0 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended 0 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Jan. 31, 2015
Warrant [Member]
Jan. 31, 2014
Warrant [Member]
Oct. 31, 2014
Consulting Agreement [Member]
Warrant [Member]
Jun. 30, 2014
Investors [Member]
Apr. 23, 2014
Equity Option [Member]
Oct. 31, 2014
Board [Member]
Oct. 31, 2014
Per Board [Member]
Restricted Stock [Member]
May 31, 2014
Investors [Member]
Apr. 30, 2014
Investors [Member]
Jan. 31, 2014
Investors [Member]
Mar. 31, 2013
Investors [Member]
Dec. 31, 2013
Investors [Member]
Oct. 31, 2014
Consultants [Member]
Dec. 19, 2014
Manatuck Hill Partners, LLC [Member]
Number of common stock shares for reverse merger   800,000                              
Issuance of common stock, shares                             3,333,375    
Issuance of common stock   $ (1,180,003)                         $ 5,000,000    
Number of common stock shares sold             66,668       133,333 416,668 300,000 236,667 533,333    
Number of common stock shares sold, value             100,000       200,002 625,001 450,000 355,000 800,000    
Stock issuance costs relating to private placement             33,258       82,796 141,791 102,166 80,536 1,604,000    
Stock issuance consisting cash             13,000       26,000 81,250 58,500 46,150 872,106    
Number of warrants issued             8,667       17,333 41,667 30,000 23,667 30,000 14,000  
Warrants issued for services             20,258       56,796 60,541 43,666 34,386 731,894    
Number of restricted shares issued during period                   8,000             200,000
Number of restricted shares issued during period, amount                               35,000  
Options, Granted    59,000 318,000           50,000 10,000              
Option granted fair value amount               136,587                  
Total intrinsic value of options outstanding and exercisable 1,082,808 219,332                              
Stock based compensation related to stock option unvested   3,055                              
Weighted average expensing period of the unvested options   2 years 8 months 27 days                              
Number of warrants forfeiture           98,000                      
Total intrinsic value of warrants outstanding and exercisable       $ 227,430 $ 1,635,801                        

Stockholders' Equity - Summary of Option Activity (Details)

v2.4.0.8
Stockholders' Equity - Summary of Option Activity (Details) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Equity [Abstract]      
Options Outstanding, Beginning balance 541,404 541,404 223,404
Options Exercisable, Beginning balance 428,845 434,177   
Options, Granted    59,000 318,000
Options, Exercised         
Options, Forfeited/Cancelled    (104,000)   
Options Outstanding, Ending balance 541,404 496,404 541,404
Options Exercisable, Ending balance 434,177 496,404 428,845
Options Outstanding, Weighted Average Exercise Price, Beginning balance $ 1.00 $ 1.00 $ 1.00
Options Exercisable, Weighted Average Exercise Price, Beginning balance $ 1.00 $ 1.00   
Weighted Average Exercise Price, Granted    $ 2.95 $ 1.00
Weighted Average Exercise Price, Exercised         
Weighted Average Exercise Price, Forfeited/Cancelled         
Options Outstanding, Weighted Average Exercise Price, Ending balance $ 1.00 $ 1.04 $ 1.00
Options Exercisable, Weighted Average Exercise Price, Ending balance $ 1.00 $ 1.02 $ 1.00

Stockholders' Equity - Summary of Option Outstanding and Exercisable (Details)

v2.4.0.8
Stockholders' Equity - Summary of Option Outstanding and Exercisable (Details) (USD $)
12 Months Ended
Jan. 31, 2015
Jan. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Jan. 31, 2015
Range Of Exercise Price One [Member]
Jan. 31, 2015
Range Of Exercise Price Two [Member]
Range of exercise price         $ 1.00 $ 2.97
Number of Options Outstanding 496,404 541,404 541,404 223,404 487,404 9,000
Weighted Average Remaining Contractual Life (in years), Options Outstanding         2 years 8 months 16 days 4 years 3 months
Weighted Average Exercise Price, Options Outstanding $ 1.04 $ 1.00 $ 1.00 $ 1.00 $ 1.00 $ 2.97
Number of Options Exercisable 496,404 434,177 428,845    481,404 4,500
Weighted Average Exercise Price, Options Exercisable $ 1.02 $ 1.00 $ 1.00    $ 0.65 $ 2.00

Stockholders' Equity - Schedule of Warrants Activity (Details)

v2.4.0.8
Stockholders' Equity - Schedule of Warrants Activity (Details) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Equity [Abstract]      
Warrants Outstanding, Beginning balance 892,067 922,067 505,400
Warrants Exercisable, Beginning balance 892,067 922,067   
Warrants, Granted 30,000 203,334 386,667
Warrants, Exercised         
Warrants, Forfeited/Cancelled    (98,000)   
Warrants Outstanding, Ending balance 922,067 1,027,401 892,067
Warrants Exercisable, Ending balance 922,067 1,027,401 892,067
Warrants Outstanding, Weighted Average Exercise Price, Beginning balance $ 1.22 $ 1.22 $ 1.00
Warrants Exercisable, Weighted Average Exercise Price, Beginning balance $ 1.22 $ 1.22   
Weighted Average Exercise Price, Granted $ 1.50 $ 2.05 $ 1.50
Weighted Average Exercise Price, Exercised         
Weighted Average Exercise Price, Forfeited/Cancelled         
Warrants Outstanding, Weighted Average Exercise Price, Ending balance $ 1.22 $ 1.27 $ 1.22
Warrants Exercisable, Weighted Average Exercise Price, Ending balance $ 1.22 $ 1.27 $ 1.22

Stockholders' Equity - Schedule of Warrants Outstanding and Exercisable (Details)

v2.4.0.8
Stockholders' Equity - Schedule of Warrants Outstanding and Exercisable (Details) (USD $)
12 Months Ended
Jan. 31, 2015
Jan. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Equity [Abstract]        
Range of exercise price, lower limit $ 1.00      
Range of exercise price, higher limit $ 2.50      
Number of Warrants Outstanding 1,027,401      
Weighted Average Remaining Contractual Life (in Years) 3 years 1 month 13 days      
Weighted Average Exercise Price, Warrants Outstanding $ 1.27      
Number of Warrants Exercisable 1,027,401 922,067 892,067   
Weighted Average Exercise Price, Warrants Exercisable $ 1.27 $ 1.22 $ 1.22   

Commitments and Contingencies (Details Narrative)

v2.4.0.8
Commitments and Contingencies (Details Narrative) (USD $)
1 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Dec. 01, 2011
Advisory Agreement One [Member]
Dec. 31, 2012
Advisory Agreement One [Member]
Spartan Capital Securities, LLC [Member]
May 02, 2013
Advisory Agreement Two [Member]
Oct. 29, 2013
Advisory Agreement Two [Member]
Spartan Capital Securities, LLC [Member]
Dec. 31, 2013
Advisory Agreement Two [Member]
Spartan Capital Securities, LLC [Member]
Oct. 22, 2013
Advisory Agreement Three [Member]
Dec. 31, 2013
Advisory Agreement Three [Member]
Spartan Capital Securities, LLC [Member]
Jan. 31, 2014
Advisory Agreement Four [Member]
Spartan Capital Securities, LLC [Member]
Jan. 31, 2015
Advisory Agreement Five [Member]
Spartan Capital Securities, LLC [Member]
Jan. 31, 2015
Minimum [Member]
Advisory Agreement [Member]
Spartan Capital Securities, LLC [Member]
Jan. 31, 2015
Maximum [Member]
Advisory Agreement [Member]
Spartan Capital Securities, LLC [Member]
Jan. 31, 2015
Year 1 [Member]
Jan. 31, 2015
Year 2 [Member]
Jan. 31, 2015
Year 2 [Member]
Minimum [Member]
Jan. 31, 2015
Year 2 [Member]
Maximum [Member]
Jan. 31, 2015
Year 3 [Member]
Jan. 31, 2015
Year 3 [Member]
Minimum [Member]
Jan. 31, 2015
Year 3 [Member]
Maximum [Member]
Jan. 31, 2015
Year 4 [Member]
Percentage of royalty rate on net sales                             6.00% 4.00%     2.00%     1.00%
Royalty net sales                             $ 500,000   $ 500,000 $ 2,500,000   $ 2,500,000 $ 20,000,000 $ 20,000,000
Royalty expenses 35,551 284,861 203,031                                      
Proceeds from private placements       6,000,000   5,000,000     2,500,000                          
Percentage of fee equal to aggregate gross proceeds       10.00%   10.00%   3.00% 3.00% 3.00%                        
Non refundable monthly fee period                         12 months 24 months                
Aggregate gross proceeds fee                         4,000,000 5,000,000                
Percentage of common stock issuable       10.00%   10.00%     10.00%                          
Payment of maximum amount paid for consideration of expenses       40,000       10,000   10,000                        
Fee paid amount         505,400     650,000   104,000 58,500 166,400                    
Number of warrants issued         505,400     333,333   53,333 30,000 91,333                    
Warrants Remaining Contractual Life         5 years     5 years 5 years 5 years 5 years 5 years                    
Warrants exercise price         $ 1.00     $ 1.50   $ 1.50 $ 1.50 $ 1.50                    
Fair value of warrants                   731,894 43,166 171,981                    
Advisory agreement description          

The Company shall pay to Spartan a non-refundable monthly fee of $10,000 over a twelve to twenty four month period upon Spartan’s satisfaction of certain thresholds (raising of aggregate gross proceeds of $4.0 mil- $5.0 mil) outlined in the Spartan Advisory Agreement.

                               
Fees cancellation on agreement amendment             $ 10,000                              

Commitments and Contingencies - Schedule of Royalty Minimum Payment by Preceding Agreement Year (Details)

v2.4.0.8
Commitments and Contingencies - Schedule of Royalty Minimum Payment by Preceding Agreement Year (Details) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Dec. 31, 2013
Minimum Royalty to be Paid $ 35,551 $ 284,861 $ 203,031
Agreement Year 1st and 2nd [Member]
     
Minimum Royalty to be Paid       
Agreement Year 3rd and 4th [Member]
     
Minimum Royalty to be Paid   50,000  
Agreement Year 5th, 6th and 7th [Member]
     
Minimum Royalty to be Paid   75,000  
Agreement Year 8th and 9th [Member]
     
Minimum Royalty to be Paid   100,000  
Agreement Year 10th and thereafter [Member]
     
Minimum Royalty to be Paid   $ 125,000  

Commitments and Contingencies - Schedule of Future Minimum Payments Under Operating Leases (Details)

v2.4.0.8
Commitments and Contingencies - Schedule of Future Minimum Payments Under Operating Leases (Details) (USD $)
Jan. 31, 2015
Commitments And Contingencies - Schedule Of Future Minimum Payments Under Operating Leases Details  
2016 $ 18,848
2017 18,848
2018 18,848
2019 18,848
2020 3,141
Total $ 78,533

Income Tax Provision (Benefit) (Details Narrative)

v2.4.0.8
Income Tax Provision (Benefit) (Details Narrative) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Valuation allowance $ 103,644 $ 1,745,469
Internal Revenue Service (IRS) [Member]
   
Percentage of ownership change   50.00%
Domestic Tax Authority [Member]
   
Net operating loss carryforward 4,800,000 8,800,000
Net operating loss carry-forward expiration year   2034
New Jersey State [Member]
   
Net operating loss carryforward $ 4,800,000 $ 8,800,000
Net operating loss carry-forward expiration year   2034

Income Tax Provision (Benefit) - Schedule of Provision for Income Tax (Details)

v2.4.0.8
Income Tax Provision (Benefit) - Schedule of Provision for Income Tax (Details) (USD $)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Income Tax Disclosure [Abstract]    
Federal current      
Federal deferred (81,819) (1,376,168)
State and local current      
State and local deferred (21,825) (369,301)
Change in valuation allowance 103,644 1,745,469
Income tax provision (benefit)      

Income Tax Provision (Benefit) - Schedule of Deferred Tax Assets (Details)

v2.4.0.8
Income Tax Provision (Benefit) - Schedule of Deferred Tax Assets (Details) (USD $)
Jan. 31, 2015
Jan. 31, 2014
Income Tax Disclosure [Abstract]    
Net operating loss carryovers $ 3,855,903 $ 2,044,894
Total deferred tax assets 3,855,903 2,044,894
Valuation allowance (3,754,914) (2,009,445)
Deferred tax asset, net of valuation allowance 100,989 35,449
Other deferred tax liabilities (100,989) (35,449)
Total deferred tax liabilities (100,989) (35,449)
Net deferred tax asset (liability)      

Income Tax Provision (Benefit) - Schedule of Effective Income Tax Rate Reconciliation (details)

v2.4.0.8
Income Tax Provision (Benefit) - Schedule of Effective Income Tax Rate Reconciliation (details)
1 Months Ended 12 Months Ended
Jan. 31, 2014
Jan. 31, 2015
Income Tax Disclosure [Abstract]    
US Federal statutory rate (34.00%) (34.00%)
State income tax, net of federal benefit (5.90%) (5.90%)
Deferred tax true-up      
Change in valuation allowance 42.50% 43.00%
Other permanent differences (2.60%) (3.00%)
Income tax provision (benefit)